Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiang Peng You Kang is a China-based healthcare services and digital health company focused on integrated medical and health management services. Public deal disclosures describe the business as a comprehensive medical and healthcare group with a self-developed Yikang International Medical and Health Service platform that connects medical resources to provide professional healthcare solutions. Shineco announced and completed the acquisition of a 51% equity interest in the company in January 2022 as part of its strategy to expand into comprehensive healthcare services and digital therapeutics, particularly in oncology. Available public information suggests XPYK is primarily a service-platform business rather than a traditional therapeutics developer, and there is no clearly disclosed drug pipeline in accessible sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiang Peng You Kang.